Efficacy of emu oil transfersomes for local transdermal delivery of 4-OH tamoxifen in the treatment of breast cancer
Oral tamoxifen used in the prevention and treatment of ductal carcinoma in situ
(DCIS)(estrogen-positive) patients has limited acceptance, due to its adverse side effects …
(DCIS)(estrogen-positive) patients has limited acceptance, due to its adverse side effects …
Development and characterization of magnetic hydrogels loaded with greenly synthesized iron-oxide nanoparticles conjugated with cisplatin
A Shammeri, R Abu-Huwaij… - Pharmaceutical …, 2024 - Taylor & Francis
A novel approach was devised to address the challenges in delivering cisplatin (CIS) for
lung cancer treatment. This involved the development of a non-invasive hydrogel delivery …
lung cancer treatment. This involved the development of a non-invasive hydrogel delivery …
Ratite oils for local transdermal therapy of 4-OH tamoxifen: development, characterization, and ex vivo evaluation
U Sundralingam, S Muniyandy… - Journal of liposome …, 2021 - Taylor & Francis
The anti-inflammatory property of ratite oils as well as its ability to act as a penetration
enhancer makes it an ideal agent to be used in transdermal formulations. The present study …
enhancer makes it an ideal agent to be used in transdermal formulations. The present study …
Influence of CYP2D6 and its polymorphic forms on the metabolism of tamoxifen in therapy of luminal forms of breast cancer
PO Yurchenko, VM Shkarupa… - Reports of …, 2024 - reports-vnmedical.com.ua
Annotation. Tamoxifen belongs to the group of selective estrogen receptor modulators
(SERM) and is metabolized by the detoxification system of xenobiotics, and the …
(SERM) and is metabolized by the detoxification system of xenobiotics, and the …